HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Romain Perrelet Selected Research

Ro 23-7553

1/20041,25-(OH)2-16ene-23yne-D3 reduces secondary hyperparathyroidism in uremic rats with little calcemic effect.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Romain Perrelet Research Topics

Disease

2Osteoporosis
01/2018 - 03/2013
2Bone Resorption
07/2004 - 03/2004
1Secondary Hyperparathyroidism
01/2004

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
07/2004 - 03/2004
1DenosumabFDA Link
01/2018
1Zoledronic Acid (Zometa)FDA Link
03/2013
1Alendronate (Alendronate Sodium)FDA LinkGeneric
07/2004
1Calcitriol (Calcijex)FDA LinkGeneric
01/2004
1Ro 23-7553IBA
01/2004

Therapy/Procedure

1Therapeutics
03/2013